Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.

finance.yahoo.com · 2026-09-13

Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 cyberattack disrupted manufacturing and shipping. The company stated it is unlikely to meet its previously issued third-quarter and full-year 2026 guidance for net sales and adjusted earnings per share. Though operations have since resumed, the incident […]

TickrTrends take: Boston Scientific operates in the Healthcare sector where device manufacturers face operational risks beyond traditional business performance metrics. The company's recent cyberattack-related guidance withdrawal represents an external disruption to execution rather than a fundamental weakness in underlying demand or product performance, which TickrTrends currently rates as undervalued. Investors monitoring valuation should distinguish between temporary operational setbacks and structural business deterioration when reassessing the company's fundamentals.

Read the full story at finance.yahoo.com →